HRMY
Price
$35.08
Change
-$0.23 (-0.65%)
Updated
Jun 4, 04:24 PM (EDT)
Capitalization
2.03B
69 days until earnings call
SAGE
Price
$6.53
Change
-$0.00 (-0.00%)
Updated
Jun 4, 04:59 PM (EDT)
Capitalization
408.91M
62 days until earnings call
Interact to see
Advertisement

HRMY vs SAGE

Header iconHRMY vs SAGE Comparison
Open Charts HRMY vs SAGEBanner chart's image
Harmony Biosciences Holdings
Price$35.08
Change-$0.23 (-0.65%)
Volume$488
Capitalization2.03B
Sage Therapeutics
Price$6.53
Change-$0.00 (-0.00%)
Volume$9.47K
Capitalization408.91M
HRMY vs SAGE Comparison Chart
Loading...
HRMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HRMY vs. SAGE commentary
Jun 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HRMY is a Buy and SAGE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 05, 2025
Stock price -- (HRMY: $35.31 vs. SAGE: $6.53)
Brand notoriety: HRMY and SAGE are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HRMY: 119% vs. SAGE: 69%
Market capitalization -- HRMY: $2.03B vs. SAGE: $408.91M
HRMY [@Biotechnology] is valued at $2.03B. SAGE’s [@Biotechnology] market capitalization is $408.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $321.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.31B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HRMY’s FA Score shows that 0 FA rating(s) are green whileSAGE’s FA Score has 1 green FA rating(s).

  • HRMY’s FA Score: 0 green, 5 red.
  • SAGE’s FA Score: 1 green, 4 red.
According to our system of comparison, HRMY is a better buy in the long-term than SAGE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HRMY’s TA Score shows that 5 TA indicator(s) are bullish while SAGE’s TA Score has 5 bullish TA indicator(s).

  • HRMY’s TA Score: 5 bullish, 5 bearish.
  • SAGE’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both HRMY and SAGE are a good buy in the short-term.

Price Growth

HRMY (@Biotechnology) experienced а +4.50% price change this week, while SAGE (@Biotechnology) price change was +0.15% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.26%. For the same industry, the average monthly price growth was +5.04%, and the average quarterly price growth was -2.58%.

Reported Earning Dates

HRMY is expected to report earnings on Aug 12, 2025.

SAGE is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Biotechnology (+6.26% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HRMY($2.03B) has a higher market cap than SAGE($409M). SAGE YTD gains are higher at: 20.258 vs. HRMY (2.616). HRMY has higher annual earnings (EBITDA): 238M vs. SAGE (-358.98M). HRMY has more cash in the bank: 507M vs. SAGE (424M). SAGE has less debt than HRMY: SAGE (11.9M) vs HRMY (176M). HRMY has higher revenues than SAGE: HRMY (745M) vs SAGE (47.4M).
HRMYSAGEHRMY / SAGE
Capitalization2.03B409M496%
EBITDA238M-358.98M-66%
Gain YTD2.61620.25813%
P/E Ratio13.48N/A-
Revenue745M47.4M1,572%
Total Cash507M424M120%
Total Debt176M11.9M1,479%
FUNDAMENTALS RATINGS
SAGE: Fundamental Ratings
SAGE
OUTLOOK RATING
1..100
51
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HRMYSAGE
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
64%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
75%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 16 days ago
77%
Declines
ODDS (%)
Bearish Trend 8 days ago
76%
Bearish Trend 8 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
71%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
HRMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SAGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JDNAX71.910.47
+0.66%
Janus Henderson Growth And Income A
CRIEX6.55N/A
N/A
CRM All Cap Value Inst
REAIX26.57N/A
N/A
American Century Real Estate I
SLESX11.18N/A
N/A
Invesco Income Advantage U.S. Fund R6
BGEEX17.49N/A
N/A
BlackRock GA Dynamic Eq K

HRMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, HRMY has been loosely correlated with SNBIF. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if HRMY jumps, then SNBIF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HRMY
1D Price
Change %
HRMY100%
-0.70%
SNBIF - HRMY
52%
Loosely correlated
N/A
SAGE - HRMY
41%
Loosely correlated
-1.36%
CYTK - HRMY
37%
Loosely correlated
+2.53%
GLYC - HRMY
35%
Loosely correlated
+3.47%
ANAB - HRMY
35%
Loosely correlated
+7.59%
More